SG11201708068PA - Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof - Google Patents
Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereofInfo
- Publication number
- SG11201708068PA SG11201708068PA SG11201708068PA SG11201708068PA SG11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- active agent
- extended release
- injectable formulations
- isoxazoline active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562144871P | 2015-04-08 | 2015-04-08 | |
PCT/US2016/026253 WO2016164487A1 (en) | 2015-04-08 | 2016-04-06 | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201708068PA true SG11201708068PA (en) | 2017-10-30 |
Family
ID=57072717
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912724SA SG10201912724SA (en) | 2015-04-08 | 2016-04-06 | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof |
SG11201708068PA SG11201708068PA (en) | 2015-04-08 | 2016-04-06 | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912724SA SG10201912724SA (en) | 2015-04-08 | 2016-04-06 | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof |
Country Status (18)
Country | Link |
---|---|
US (2) | US20170020848A1 (es) |
EP (1) | EP3280413A1 (es) |
JP (2) | JP6824900B2 (es) |
KR (1) | KR102593069B1 (es) |
CN (1) | CN108055825B (es) |
AR (1) | AR104212A1 (es) |
AU (3) | AU2016246598B2 (es) |
BR (1) | BR112017021073A2 (es) |
CA (1) | CA2981797C (es) |
CL (1) | CL2017002536A1 (es) |
CO (1) | CO2017010065A2 (es) |
EA (2) | EA036272B1 (es) |
IL (1) | IL254813B (es) |
MX (2) | MX2017012848A (es) |
NZ (1) | NZ736374A (es) |
SG (2) | SG10201912724SA (es) |
UY (1) | UY36610A (es) |
WO (1) | WO2016164487A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY37137A (es) * | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
WO2018039508A1 (en) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
UY37665A (es) * | 2017-04-05 | 2018-10-31 | Merial Inc | Formas cristalinas de (s)-afoxolaner |
EP3609470B1 (en) | 2017-04-13 | 2023-11-22 | Ceva Santé Animale | Implant for treating parasites infestations |
IL274065B2 (en) | 2017-11-07 | 2023-09-01 | Intervet Int Bv | Injectable isoxazoline pharmaceutical compounds and their antiparasitic use |
BR112020008848A2 (pt) | 2017-11-07 | 2020-10-20 | Intervet International B.V. | processo de preparação de partículas de isoxazolina de tamanho grande |
CA3083683A1 (en) * | 2017-12-12 | 2019-06-20 | Intervet International B.V. | Implantable isoxazoline pharmaceutical compositions and uses thereof |
TWI812673B (zh) | 2018-02-12 | 2023-08-21 | 美商富曼西公司 | 用於防治無脊椎害蟲之萘異噁唑啉化合物 |
AR116524A1 (es) * | 2018-10-04 | 2021-05-19 | Elanco Tiergesundheit Ag | Potenciación de tratamiento de helmintos |
PE20220173A1 (es) | 2019-05-03 | 2022-01-28 | Intervet Int Bv | Composiciones farmaceuticas inyectables y usos de las mismas |
DK4153133T3 (da) | 2020-05-20 | 2024-02-05 | Intervet Int Bv | Injicerbare farmaceutiske sammensætninger og anvendelser deraf |
IL309666A (en) | 2021-07-09 | 2024-02-01 | Plexium Inc | Aryl compounds and pharmaceutical preparations that modulate IKZF2 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
JPS4914624A (es) | 1972-06-08 | 1974-02-08 | ||
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4134973A (en) | 1977-04-11 | 1979-01-16 | Merck & Co., Inc. | Carbohydrate derivatives of milbemycin and processes therefor |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
US4144352A (en) | 1977-12-19 | 1979-03-13 | Merck & Co., Inc. | Milbemycin compounds as anthelmintic agents |
US4203976A (en) | 1978-08-02 | 1980-05-20 | Merck & Co., Inc. | Sugar derivatives of C-076 compounds |
JPS57139012A (en) | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
US4427663A (en) | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
DE3681465D1 (es) | 1985-02-04 | 1991-10-24 | Nihon Bayer Agrochem K.K., Tokio/Tokyo, Jp | |
EP0237482A1 (de) | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen |
DE3767560D1 (de) | 1986-03-25 | 1991-02-28 | Sankyo Co | Makrolide verbindungen, ihre herstellung und verwendung. |
ATE75745T1 (de) | 1986-07-02 | 1992-05-15 | Ciba Geigy Ag | Pestizide. |
US4855317A (en) | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
US4871719A (en) | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
US4874749A (en) | 1987-07-31 | 1989-10-17 | Merck & Co., Inc. | 4"-Deoxy-4-N-methylamino avermectin Bla/Blb |
EP0319142B1 (en) | 1987-11-03 | 1994-04-06 | Beecham Group Plc | Intermediates for the preparation of anthelmintic macrolide antibiotics |
NZ232422A (en) | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
NZ247278A (en) | 1991-02-12 | 1995-03-28 | Ancare Distributors | Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier |
US5330768A (en) | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US5345377A (en) | 1992-10-30 | 1994-09-06 | Electric Power Research Institute, Inc. | Harmonic controller for an active power line conditioner |
GB9300883D0 (en) | 1993-01-18 | 1993-03-10 | Pfizer Ltd | Antiparasitic agents |
AUPM969994A0 (en) | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
US6207647B1 (en) | 1997-07-18 | 2001-03-27 | Smithkline Beecham Corporation | RatA |
US6733767B2 (en) * | 1998-03-19 | 2004-05-11 | Merck & Co., Inc. | Liquid polymeric compositions for controlled release of bioactive substances |
CA2558848C (en) | 2004-03-05 | 2013-11-19 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and pesticide |
US8362086B2 (en) | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
EP1932836B1 (en) | 2005-09-02 | 2013-11-06 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
JP2009519937A (ja) | 2005-12-14 | 2009-05-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 無脊椎有害生物防除用イソオキサゾリン |
TW200803740A (en) | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
AU2007240954A1 (en) | 2006-04-20 | 2007-11-01 | E. I. Du Pont De Nemours And Company | Pyrazolines for controlling invertebrate pests |
JP2008044880A (ja) | 2006-08-15 | 2008-02-28 | Bayer Cropscience Ag | 殺虫性イソオキサゾリン類 |
JP5256753B2 (ja) | 2007-03-29 | 2013-08-07 | 住友化学株式会社 | イソオキサゾリン化合物とその有害生物防除用途 |
WO2008122375A2 (en) | 2007-04-10 | 2008-10-16 | Bayer Cropscience Ag | Insecticidal aryl isoxazoline derivatives |
MX2009013469A (es) | 2007-06-13 | 2010-01-20 | Du Pont | Insecticidas de isoxazolina. |
TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
TWI556741B (zh) | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
WO2009045999A1 (en) | 2007-10-03 | 2009-04-09 | E. I. Du Pont De Nemours And Company | Naphthalene isoxazoline compounds for control of invertebrate pests |
EP2306837B2 (en) | 2008-07-09 | 2023-10-25 | Basf Se | Pesticidal active mixtures comprising isoxazoline compounds i |
EP2379544B1 (en) * | 2008-12-18 | 2013-10-16 | Novartis AG | Isoxazolines derivatives and their use as pesticide |
MX2020001453A (es) * | 2009-12-17 | 2021-07-29 | Merial Ltd | Compuestos de dihidroazol antiparasiticos y composiciones que comprenden los mismos. |
MD4363C1 (ro) * | 2010-05-27 | 2016-03-31 | E.I. Du Pont De Nemours And Company | Forma cristalină a 4-[5-[3-cloro-5-(trifluorometil)fenil]-4,5-dihidro-5-(trifluorometil)-3-izoxazolil]-N-[2-oxo-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalencarboxamidei şi utilizările sale |
DK178277B1 (da) * | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
CA2822853C (en) | 2010-12-27 | 2021-05-11 | Intervet International B.V. | Topical localized isoxazoline formulation comprising glycofurol |
CA2826067A1 (en) * | 2011-02-10 | 2012-08-16 | Novartis Ag | Isoxazoline derivatives for controlling invertebrate pests |
PT2683723T (pt) | 2011-03-10 | 2016-08-05 | Zoetis Services Llc | Derivados espirocíclicos de isoxazolina como agentes antiparasitários |
CN103502246A (zh) * | 2011-03-10 | 2014-01-08 | 诺瓦提斯公司 | 异噁唑衍生物 |
TR201903499T4 (tr) | 2011-09-12 | 2019-04-22 | Merial Inc | Bi̇r i̇zoksazoli̇n akti̇f maddesi̇ni̇ i̇çeren parazi̇ti̇si̇dal bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari |
AR088668A1 (es) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
AR088669A1 (es) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
EP3351546B1 (en) * | 2011-12-02 | 2024-02-14 | Boehringer Ingelheim Vetmedica GmbH | Long-acting injectable moxidectin formulations |
ES2515015B2 (es) | 2012-02-06 | 2016-03-01 | Merial Limited | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas |
CN104603140A (zh) | 2012-09-07 | 2015-05-06 | 佐蒂斯有限责任公司 | 作为抗寄生虫剂的螺环异噁唑啉 |
PL2892347T3 (pl) | 2012-09-07 | 2019-12-31 | Zoetis Services Llc | Kombinacje pasożytobójcze spirocyklicznej izoksazoliny |
EP2999339B1 (en) | 2013-05-20 | 2019-06-19 | Zoetis Services LLC | Long-acting spiro-isoxazoline antiparasitic compositions |
EP3052080A1 (en) * | 2013-09-30 | 2016-08-10 | Zoetis Services LLC | Long-acting spiro-isoxazoline formulations |
-
2016
- 2016-04-06 EA EA201792235A patent/EA036272B1/ru not_active IP Right Cessation
- 2016-04-06 NZ NZ736374A patent/NZ736374A/en unknown
- 2016-04-06 SG SG10201912724SA patent/SG10201912724SA/en unknown
- 2016-04-06 EP EP16720949.3A patent/EP3280413A1/en active Pending
- 2016-04-06 KR KR1020177032205A patent/KR102593069B1/ko active IP Right Grant
- 2016-04-06 AU AU2016246598A patent/AU2016246598B2/en active Active
- 2016-04-06 EA EA202090762A patent/EA202090762A1/ru unknown
- 2016-04-06 SG SG11201708068PA patent/SG11201708068PA/en unknown
- 2016-04-06 WO PCT/US2016/026253 patent/WO2016164487A1/en active Application Filing
- 2016-04-06 CN CN201680031640.6A patent/CN108055825B/zh active Active
- 2016-04-06 US US15/092,491 patent/US20170020848A1/en not_active Abandoned
- 2016-04-06 BR BR112017021073A patent/BR112017021073A2/pt not_active Application Discontinuation
- 2016-04-06 MX MX2017012848A patent/MX2017012848A/es unknown
- 2016-04-06 CA CA2981797A patent/CA2981797C/en active Active
- 2016-04-06 JP JP2017553068A patent/JP6824900B2/ja active Active
- 2016-04-08 UY UY0001036610A patent/UY36610A/es active IP Right Grant
- 2016-04-08 AR ARP160100953A patent/AR104212A1/es active IP Right Grant
-
2017
- 2017-10-01 IL IL254813A patent/IL254813B/en active IP Right Grant
- 2017-10-04 CO CONC2017/0010065A patent/CO2017010065A2/es unknown
- 2017-10-05 MX MX2022010831A patent/MX2022010831A/es unknown
- 2017-10-06 CL CL2017002536A patent/CL2017002536A1/es unknown
-
2020
- 2020-07-30 AU AU2020210266A patent/AU2020210266B2/en active Active
- 2020-11-20 JP JP2020193357A patent/JP2021050206A/ja active Pending
-
2021
- 2021-05-24 US US17/327,929 patent/US20210299104A1/en active Pending
-
2022
- 2022-03-24 AU AU2022202035A patent/AU2022202035A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN108055825B (zh) | 2021-03-30 |
WO2016164487A1 (en) | 2016-10-13 |
CN108055825A (zh) | 2018-05-18 |
CA2981797C (en) | 2023-11-21 |
BR112017021073A2 (pt) | 2018-07-03 |
CO2017010065A2 (es) | 2018-01-05 |
KR102593069B1 (ko) | 2023-10-23 |
CA2981797A1 (en) | 2016-10-13 |
NZ736374A (en) | 2024-02-23 |
US20170020848A1 (en) | 2017-01-26 |
AU2016246598A1 (en) | 2017-11-02 |
IL254813A0 (en) | 2017-12-31 |
AU2022202035A1 (en) | 2022-04-14 |
KR20170134700A (ko) | 2017-12-06 |
US20210299104A1 (en) | 2021-09-30 |
AU2020210266A1 (en) | 2020-08-20 |
SG10201912724SA (en) | 2020-02-27 |
CL2017002536A1 (es) | 2018-04-20 |
MX2022010831A (es) | 2022-09-29 |
UY36610A (es) | 2016-10-31 |
EA202090762A1 (ru) | 2020-09-08 |
EP3280413A1 (en) | 2018-02-14 |
JP6824900B2 (ja) | 2021-02-03 |
MX2017012848A (es) | 2018-01-15 |
JP2018510897A (ja) | 2018-04-19 |
AU2020210266B2 (en) | 2022-03-10 |
JP2021050206A (ja) | 2021-04-01 |
IL254813B (en) | 2020-03-31 |
AR104212A1 (es) | 2017-07-05 |
EA036272B1 (ru) | 2020-10-21 |
EA201792235A1 (ru) | 2018-01-31 |
AU2016246598B2 (en) | 2020-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL254813A0 (en) | Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof | |
ZA201805476B (en) | Antiparasitic isoxazoline compounds, long¿acting injectable formulations comprising them, methods and uses thereof | |
IL249370A0 (en) | Fap-enabled medical substances and related uses | |
HK1251183A1 (zh) | 生物綴合物及其用途 | |
GB201512203D0 (en) | Agents,uses and methods | |
SG11201705034RA (en) | Copolymer and oily gelling agent | |
HK1256674A1 (zh) | 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途 | |
PL3232780T3 (pl) | Kompozycje adiuwantowe zawierające wodny elektrolit, kompozycje zawierające składnik czynny i ich zastosowanie | |
SG11201803669UA (en) | Microorganism-controlling agent and miticidal composition | |
HK1259291A1 (zh) | 遊戲裝置、遊戲系統以及程序 | |
IL248586A0 (en) | A pde10 suppressor that is optically active, preparations containing it, methods for its preparation and use in it | |
GB201512215D0 (en) | Agents,uses and methods | |
PT3011831T (pt) | Limoneno: formulação e utilização inseticida | |
PL3307275T3 (pl) | Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie | |
HK1251924A1 (zh) | Foxm1衍生的肽和包含它們的疫苗 | |
PL3253857T3 (pl) | Preparaty wodne, ich wytwarzanie i zastosowanie | |
IL246606A0 (en) | Mir-122 as an active micro-rna, compounds containing it and its uses. | |
PL3072529T3 (pl) | Kompozycja zawierająca wemurafenib i HPMC-AS | |
AP2017009706A0 (en) | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof | |
HK1251928A1 (zh) | Mphosph1衍生的肽和包括它的疫苗 | |
ZA201708307B (en) | Improved herbicidal composition, method and use | |
GB201718394D0 (en) | Some alcohol ethoxyles, their application and use | |
PT3290048T (pt) | Agente indutor de imunidade | |
GB201518375D0 (en) | Agents,uses and methods | |
GB201512211D0 (en) | Agents, uses and methods |